Drug interactions
Brexucabtagene autoleucel + Ifosfamide
Severity: Major
Brexucabtagene autoleucel and Ifosfamide: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ifosfamide causes myelosuppression and immunosuppression, and brexucabtagene autoleucel can cause prolonged cytopenias and infections. Concurrent exposure increases infection risk and may impair CAR-T cell function.
What this interaction means in plain words
Brexucabtagene autoleucel and Ifosfamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Ifosfamide belongs to Oncology.
Why it happens
Additive immunosuppression and myelosuppression; cytotoxic therapy may reduce CAR-T expansion.
What to do
Avoid chemotherapy except planned lymphodepletion around infusion and follow the recommended washout before leukapheresis. Monitor counts and infection afterwards.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Ifosfamide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ifosfamide
- Adenovirus types 4 and 7 live + Ifosfamide Contraindicated
- Ifosfamide + Measles mumps and rubella vaccine Contraindicated
- Ifosfamide + Measles mumps and rubella vaccine live Contraindicated
- Ifosfamide + Measles mumps rubella and varicella vaccine live Contraindicated
- Ifosfamide + Measles vaccine Contraindicated
- Ifosfamide + Rotavirus oral vaccine live Contraindicated
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Ifosfamide?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Ifosfamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ifosfamide causes myelosuppression and immunosuppression, and brexucabtagene autoleucel can cause prolonged cytopenias and infections. Concurrent exposure increases infection risk and may impair CAR-T cell function.
How serious is the interaction between Brexucabtagene autoleucel and Ifosfamide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid chemotherapy except planned lymphodepletion around infusion and follow the recommended washout before leukapheresis. Monitor counts and infection afterwards.
What other medicines interact with Ifosfamide?
MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
